Development of carbon monoxide releasing molecules for the treatment of rheumatoid arthritis

Project Information

CORMRA

Grant agreement ID: 230629

Project closed

Start date 1 November 2009

End date 31 October 2011

Funded under

• Specific Programme "Capacities": Research for the benefit of SMEs

Total cost € 1 424 000,00

EU contribution € 1 100 000,00

Coordinated by

Alfama - Investigacao e Desenvolvimento de Produtos Farmaceuticos, Lda.
Portugal